American Renal Associates (ARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | |
| Sales | 560,734 | 495,926 |
| Cost of Goods | 329,847 | 288,384 |
| Gross Profit | 230,887 | 207,542 |
| Operating Expenses | 92,400 | 97,264 |
| Operating Income | 139,334 | 110,662 |
| Interest Expense | 44,070 | 43,314 |
| Other Income | 0 | -33,921 |
| Pre-tax Income | 95,264 | 33,427 |
| Income Tax | 12,858 | -8,200 |
| Net Income Continuous | 82,406 | 41,627 |
| Minority Interests | 66,209 | 62,074 |
| Net Income | $16,197 | $-20,447 |
| EPS Basic Total Ops | 0.74 | -0.94 |
| EPS Basic Continuous Ops | 3.76 | 1.92 |
| EPS Diluted Total Ops | 0.73 | -0.94 |
| EPS Diluted Continuous Ops | 3.69 | 1.92 |
| EBITDA(a) | $170,683 | $137,104 |